Epitranscriptomic Approach: To Improve the Efficacy of ICB Therapy by Co-Targeting Intracellular Checkpoint CISH
Cellular immunotherapy has recently emerged as a fourth pillar in cancer treatment co-joining surgery, chemotherapy and radiotherapy. Where, the discovery of immune checkpoint blockage or inhibition (ICB/ICI), anti-PD-1/PD-L1 and anti-CTLA4-based, therapy has revolutionized the class of cancer treat...
Main Authors: | Sunil Kumar, Parth Sarthi, Indra Mani, Muhammad Umer Ashraf, Myeong-Ho Kang, Vishal Kumar, Yong-Soo Bae |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/9/2250 |
Similar Items
-
Disruption of CISH promotes the antitumor activity of human T cells and decreases PD-1 expression levels
by: Jiang Lv, et al.
Published: (2023-03-01) -
Immunotherapeutic Potential of m6A-Modifiers and MicroRNAs in Controlling Acute Myeloid Leukaemia
by: Sunil Kumar, et al.
Published: (2021-06-01) -
Role of Cytokine-Inducible SH2 Domain-Containing (CISH) Protein in the Regulation of Erythropoiesis
by: Saeed Maymand, et al.
Published: (2023-10-01) -
CISH Expression Is Associated with Metastasis-Free Interval in Triple-Negative Breast Cancer and Refines the Prognostic Value of PDL1 Expression
by: Laurys Boudin, et al.
Published: (2022-07-01) -
Cish knockout mice exhibit similar outcomes to malaria infection despite altered hematopoietic responses
by: Asha L. Lakkavaram, et al.
Published: (2023-11-01)